Abstract

Raising the Profile of Cancer of Unknown Primary

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
N Pavlidis ... F.A Greco
Annals of Oncology | VOL. 22
N Pavlidis, et. al.N Pavlidis ... F.A Greco
01 Sep 2011
Blinded Comparator Study of Immunohistochemical Analysis versus a 92-Gene Cancer Classifier in the Diagnosis of the Primary Site in Metastatic Tumors
Veena Singh ... Lawrence M Weiss
The Journal of Molecular Diagnostics | VOL. 15
Veena Singh, et. al.Veena Singh ... Lawrence M Weiss
31 Dec 2013
Molecular Diagnosis of the Tissue of Origin in Cancer of Unknown Primary Site: Useful in Patient Management
F Anthony Greco
Current Treatment Options in Oncology | VOL. 14
F Anthony GrecoF Anthony Greco
29 Aug 2013
Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
Claire M Vajdic ... Linda Mileshkin
Internal medicine journal | VOL. 47
Claire M Vajdic, et. al.Claire M Vajdic ... Linda Mileshkin
01 Apr 2017
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers